fda warning letter compounding semaglutide october 2025 Drug compounders sue over declaration ending Wegovy shortage Hims & Hers' Woes Compound

For branded companies, a competitors successful CIP challenge can also create freedom to operate in formulation or indication space that the CIP was protecting

Switching between different GLP-1 receptor agonist drugs is unlikely to significantly change your gallstone risk

The needle is noticeably thinner than 28G and most users report significantly less pain at insertion

Andrew introduces an observational study investigating the influence of light exposure on circadian clock regulation and its link to mental health, while Peter covers a phase III clinical trial employing immune checkpoint inhibitors for the treatment of metastatic cancer

Protect from light, moisture, and oxidizing agents at all times